Alex Haragan

University of Liverpool, Pathologist

UK

Alexander Haragan is a pathologist based in Liverpool with a clinical and research interest in thoracic and molecular pathology.

His main research interests are around the tumour immune microenvironment, PD-L1 expression in NSCLC, and the use of digital pathology and other techniques to better understand how these can be better used to predict response to immuno-modulatory treatment.

Graduating from the University of Aberdeen with his Medical Degree and first class honours in Biomedical Sciences, Dr Haragan also holds a distinction grade Masters in Pharmacogenomics and has attained his PhD in Immuno-oncology and Clinical Pharmacology.

Dr Haragan's research has been funded with awards from prestigious funding bodies including the MRC and RCUK/UKRI Innovation Fellowship, sits as part of the UKNEQAS scientific advisory board and strongly believes in his working closely with industrial colleagues and public bodies as the key to successful future development of modern pathology.